Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $53.84M.
ENTERPRISE VALUE (EV)
$53.84M
Inogen, Inc.
Market Cap
$157.57M
Enterprise Value (EV)
$53.84M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Inogen, Inc. (INGN) | $157.57M | $53.84M |
| Minerva Neurosciences, Inc. (NERV)vs › | $159.09M | $134.44M |
| ALX Oncology Holdings Inc. (ALXO)vs › | $153.40M | $140.42M |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $162.60M | $179.97M |
| PepGen Inc. (PEPG)vs › | $162.89M | $156.22M |
| Coherus Oncology, Inc. (CHRS)vs › | $163.00M | $117.78M |
| Codexis, Inc. (CDXS)vs › | $151.66M | $197.08M |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.58M | $133.29M |
| Quanterix Corporation (QTRX)vs › | $164.16M | $153.38M |
| OptimizeRx Corp. (OPRX)vs › | $165.58M | $160.97M |
Market Cap
$157.57M
Total Debt
$0.00
Cash
$103.73M
Enterprise Value
$53.84M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
